Regeneron stock gains after strong Q2 2026 earnings beat
Published on 09/10/2026 at 16:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Regeneron Pharmaceuticals, Inc. stock (ISIN US75886F1075) closed at USD 810.31 on Nasdaq on September 8, 2026, giving the biotech group a market capitalization of USD 83.43 billion per Yahoo Finance data.
Q2 2026 results deliver a clear earnings surprise
According to the biotech earnings overview from MarketBeat, Regeneron reported earnings per share of USD 14.29 in Q2 2026, beating the consensus estimate of USD 10.16 by USD 4.13.
The same overview shows that Q2 2026 revenue reached USD 4.29 billion, compared with analyst expectations of USD 3.82 billion, a positive surprise of USD 0.47 billion in the quarter.MarketBeat
Analysts keep a Moderate Buy view with limited upside
Based on 24 Wall Street analyst ratings over the past twelve months, Regeneron stock currently carries a consensus rating of Moderate Buy, with 14 Buy recommendations and 10 Hold ratings, as reported by MarketBeat on September 10, 2026.
The average 12?month price target compiled by MarketBeat stands at USD 800.36, implying a mild downside of 0.90 percent versus a current reference price of USD 807.65 cited in the same overview.
Stock trades near its 52-week high after strong run
Per the performance snapshot from Yahoo Finance, Regeneron shares delivered a 43.84 percent gain over the past 52 weeks as of September 8, 2026, while the one?month return stood at 0.19 percent.
The same data set shows that the closing price of USD 810.31 on September 8, 2026, was close to the upper end of the past?year trading range, underlining how much the strong Q2 2026 earnings beat has already been reflected in the stock.Yahoo Finance
Closing price and investor takeaway
As of the completed trading day on September 8, 2026, Regeneron stock closed at USD 810.31 on Nasdaq, and with analysts seeing an average target near USD 800.36, investors now face a share price that already discounts much of the recent earnings strength while still being supported by solid fundamental growth.
Regeneron stock facts
- Company: Regeneron Pharmaceuticals, Inc.
- ISIN: US75886F1075
- Ticker: REGN
- Trading venue: Nasdaq
- Price (as of September 8, 2026): 810.31 USD
- Market capitalization: 83.43 billion USD (as of September 8, 2026)
- Sector / Industry: Health Care / Biotechnology
- Index membership: S&P 500
More news and analyses on Regeneron Pharmaceuticals, Inc. stock
